Nasdaq
CMMB
Chemomab Therapeutics Ltd.
- Health Care
- Israel
- Listed 2019
- 1 day
- +2.9%
- 1 month
- −35.0%
- 1 year
- −54.1%
$1.80 · Mkt cap $12.9M · P/E 100
At the 6 Aug 2026 close
A foreign company trading in the US through depositary receipts.
Nasdaq
Chemomab Therapeutics Ltd.
$1.80 · Mkt cap $12.9M · P/E 100
At the 6 Aug 2026 close
A foreign company trading in the US through depositary receipts.
Chemomab Therapeutics Ltd. trades under the ticker CMMB on Nasdaq, in the Health Care sector (Biotechnology: Pharmaceutical Preparations). It has been listed since 2019. Its market capitalisation is $12.9M. The last closing price was $1.80, on 6 Aug 2026. It trades at 100 times its last reported annual diluted earnings per share. Over the past year the share price is −54.1%, and −35.0% over the past month. Returns are price returns and exclude dividends.
This page exists because CMMB is one of the shares What A Share can show you. It is not a recommendation, and its appearance here says nothing about whether the company is worth owning.